C12N 2710/16533
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/16533 (Use of viral protein as therapeutic agent other than vaccine) appears on 0 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 0
- Published applications
- 3
- Assignees
- 1
- Inventors
- 7
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Peptides with anti-angiogenic activity21 Nov 2024US 2024/0382555 A1CHEIRONTECH S.r.l.
- Use of the u94 molecule of human herpesvirus 6 and derivatives thereof to increase or induce the expression of the hla-g molecule12 Aug 2021US 2021/0246456 A1
- Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children6 Sep 2007US 2007/0207169 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.